These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 22420065
1. Controlled substances and List I chemical registration and reregistration fees. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2012 Mar 15; 77(51):15234-50. PubMed ID: 22420065 [Abstract] [Full Text] [Related]
2. Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2002 Aug 09; 67(154):51987-52007. PubMed ID: 12194173 [Abstract] [Full Text] [Related]
3. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2008 Jul 25; 73(144):43355-7. PubMed ID: 18949877 [Abstract] [Full Text] [Related]
4. Registration and reregistration application fees. Final rule; remanded for further notice and comment. Drug Enforcement Administration (DEA), Justice. Fed Regist; 1996 Dec 30; 61(251):68624-6. PubMed ID: 12192680 [Abstract] [Full Text] [Related]
8. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2010 Dec 20; 75(243):79296-300. PubMed ID: 21171485 [Abstract] [Full Text] [Related]
11. Schedule of controlled substances: placement of dichloralphenazone into Schedule IV. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2001 Aug 16; 66(159):42943-4. PubMed ID: 11794309 [Abstract] [Full Text] [Related]
13. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule. Drug Enforcement Administration, Department of Justice. Fed Regist; 2005 Jul 28; 70(144):43633-5. PubMed ID: 16050051 [Abstract] [Full Text] [Related]
15. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule. Drug Enforcement Administration, Department of Justice. Fed Regist; 2009 May 21; 74(97):23790-3. PubMed ID: 19507329 [Abstract] [Full Text] [Related]
18. Exemption from import/export requirements for personal medical use. Final rule. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2004 Sep 14; 69(177):55343-7. PubMed ID: 15366181 [Abstract] [Full Text] [Related]
19. Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments. Drug Enforcement Administration (DEA), Department of Justice. Fed Regist; 2009 Apr 06; 74(64):15595-625. PubMed ID: 19507319 [Abstract] [Full Text] [Related]
20. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule. Drug Enforcement Administration (DEA), Justice. Fed Regist; 2002 Mar 28; 67(60):14853-62. PubMed ID: 11922057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]